The New York-based Deloitte announced it has acquired the Newton, Mass.-based Recombinant Data Corp., a data warehousing and analytics provider. Recombinant Data, Deloitte says, uses their warehousing and clinical intelligence software to enable advances in personalized medicine, translational research, and healthcare performance management.
Peter Emerson, CEO of Recombinant, said in a statement: "This will allow us to make a greater impact on clients and the direction of health care; Deloitte and Recombinant share the same vision on how the industry is changing, and our combination provides a level of scale that can help reshape the clinical informatics industry."
Recombinant, founded in 2005, will become a part of Deloitte Consulting Innovation under the name "Recombinant by Deloitte." The company, Deloitte says, has products that can bolster value-based payment models, create performance management solutions for accountable care organizations (ACOs), and allow federal agencies and life sciences companies to conduct translational research. The company possesses a multitude of government customers.
While stolen financial data still has a higher market value than stolen medical records, as financial data can be monetized faster, there are indications that there is ongoing development of a market for stolen medical data, according to an Intel Security McAfee Labs report.
A phishing scam at Baystate Health in Springfield, Mass. has potentially exposed the personal data of 13,000 patients, according to a privacy statement from the patient care organization and a report from MassLive.
In an update, DirectTrust reported significant growth in Direct exchange of health information and the number of trusted Direct addressed enabled to share personal health information (PHI) in the third quarter of 2016.
Eleven private insurers, including Aetna, Humana and Anthem, are urging the Congressional Budget Office (CBO) to consider the experience of commercial insurers when evaluating the impact of telemedicine coverage in Medicare.
With the aim of improving patient safety monitoring, the Agency for Healthcare Research and Quality (AHRQ) within the U.S. Department of Health and Human Services (HHS) is currently developing and testing an improved patient safety surveillance system.